AVII -- a small biopharm -- has been up as much as 25% today. And it's had more than twice the volume of GILD, a $63/share biopharm giant.
And this is after AVII posted 10 percent gains the previous two days. The only news has been a paid-for piece of analysis.
Absent any actual news or insider buying, what might cause this level of buying frenzy? I ask in a general context, if not specific to this particular stock.
curt, still following Taylor cycles on paper, will begin trading it with SPY options as soon as I have a few rules for entries and exits; so far, six months along now, it's been more right then wrong, which is quite an edge in this business.
VLNC's upward trend of late comes in the wake of its latest conference call last week. I listened to most of it and they seemed to downplay any immediate uptick due to laptop manufacturers shifting to their style of batteries (longterm: they hope so.)
They did say, however, that they expected to double their second Q revenue due mostly to a rise in large format sales (maritime, cars, etc) and some smaller units that were supposed to sell a few months ago are only now shipping.
I've been trading Mini-Dow Futures on the multi-day forecast. It's been pretty good on the span of the forecast, as long as you can handle the intraday ups and downs.
TaylorTrends.com
ReplyDeleteIs anyone trading Taylor's forcasts? What indice / etf / option are you finding correlates to his forcasts? Any back testing?
I've started to paper trade an s&p etf on the weekly trend forcast and making a profit (small).
tnx curt
AVII -- a small biopharm -- has been up as much as 25% today. And it's had more than twice the volume of GILD, a $63/share biopharm giant.
ReplyDeleteAnd this is after AVII posted 10 percent gains the previous two days. The only news has been a paid-for piece of analysis.
Absent any actual news or insider buying, what might cause this level of buying frenzy? I ask in a general context, if not specific to this particular stock.
Jon
Jon, AVII showing textbook bullish action on daily and weekly charts; let's hope it's a precursor for entire biotech group bottoming in here.
ReplyDeleteA
curt, still following Taylor cycles on paper, will begin trading it with SPY options as soon as I have a few rules for entries and exits; so far, six months along now, it's been more right then wrong, which is quite an edge in this business.
ReplyDeleteA
VLNC's upward trend of late comes in the wake of its latest conference call last week. I listened to most of it and they seemed to downplay any immediate uptick due to laptop manufacturers shifting to their style of batteries (longterm: they hope so.)
ReplyDeleteThey did say, however, that they expected to double their second Q revenue due mostly to a rise in large format sales (maritime, cars, etc) and some smaller units that were supposed to sell a few months ago are only now shipping.
Jon
anybody have thoughts concerning vlnc, avii?
ReplyDeleteI've been trading Mini-Dow Futures on the multi-day forecast. It's been pretty good on the span of the forecast, as long as you can handle the intraday ups and downs.
ReplyDeleteMark